Literature DB >> 12482378

Cryopreservation of peripheral blood mononuclear cells does not significantly affect the levels of spontaneous apoptosis after 24-h culture.

Evelyn Kety Pratt Riccio1, Ivan Neves, Dalma Maria Banic, Suzana Corte-Real, Maria das Graças Alecrim, Mariza Morgado, Cláudio Tadeu Daniel-Ribeiro, Maria de Fátima Ferreira-da-Cruz.   

Abstract

Studies performed with malaria patients living in endemic areas are frequently conducted in laboratories located hundreds of kilometer away from research centers, due to the difficulties in performing the assays in field conditions. Thus, we considered the potential indication of cryopreservation of peripheral blood mononuclear cells (PBMC), in most fieldwork, and decided to evaluate the effect of cryopreservation of PBMC on spontaneous apoptosis. The membrane integrity of PBMC was tested using three previously described protocols of cryopreservation. Cell samples were obtained from 19 healthy volunteers. Percentage of apoptotic nuclei in short-term PBMC cultures was determined by a sensitive method using 7-aminoactinomycin D followed by flow cytometry. Our results indicate that although cryopreservation can to some extent affect lymphocyte membrane integrity rates, flow cytometry analysis showed that frequencies of spontaneous apoptosis in cryopreserved cells were not significantly modified after 24-h culture. It is concluded that cryopreserved PBMC could be used for measuring spontaneous apoptosis and therefore, could be employed for the study of populations living in areas distant from research centers, allowing the comparative evaluation of samples obtained at different time.

Entities:  

Mesh:

Year:  2002        PMID: 12482378     DOI: 10.1016/s0011-2240(02)00121-9

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  9 in total

1.  Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions.

Authors:  Jeffrey G Smith; Heather R Joseph; Tina Green; Jodie A Field; Melissa Wooters; Robin M Kaufhold; Joseph Antonello; Michael J Caulfield
Journal:  Clin Vaccine Immunol       Date:  2007-03-21

2.  Cryopreservation: An emerging paradigm change.

Authors:  John G Baust; Dayong Gao; John M Baust
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

3.  Viable mononuclear cell stability study for implementation in a proficiency testing program: impact of shipment conditions.

Authors:  Olga A Kofanova; Kristine Davis; Barbara Glazer; Yvonne De Souza; Joseph Kessler; Fotini Betsou
Journal:  Biopreserv Biobank       Date:  2014-06       Impact factor: 2.300

4.  Toward Optimal Cryopreservation and Storage for Achievement of High Cell Recovery and Maintenance of Cell Viability and T Cell Functionality.

Authors:  Stephanie Angel; Hagen von Briesen; Young-Joo Oh; Marko K Baller; Heiko Zimmermann; Anja Germann
Journal:  Biopreserv Biobank       Date:  2016-10-28       Impact factor: 2.300

5.  Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting.

Authors:  Robert E Olemukan; Leigh Anne Eller; Benson J Ouma; Ben Etonu; Simon Erima; Prossy Naluyima; Denis Kyabaggu; Josephine H Cox; Johan K Sandberg; Fred Wabwire-Mangen; Nelson L Michael; Merlin L Robb; Mark S de Souza; Michael A Eller
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

6.  Value of a quality assessment program in optimizing cryopreservation of peripheral blood mononuclear cells in a multicenter study.

Authors:  Najib Aziz; Joseph B Margolick; Roger Detels; Charles R Rinaldo; John Phair; Beth D Jamieson; Anthony W Butch
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

7.  Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants.

Authors:  Chia-Hsing Pi; Kathlyn Hornberger; Peter Dosa; Allison Hubel
Journal:  Cytotherapy       Date:  2020-03-25       Impact factor: 5.414

8.  Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.

Authors:  Constance Ducar; Donna Smith; Cris Pinzon; Michael Stirewalt; Cristine Cooper; M Juliana McElrath; John Hural
Journal:  J Immunol Methods       Date:  2014-04-04       Impact factor: 2.303

9.  Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil.

Authors:  Evelyn K P Riccio; Paulo R R Totino; Lilian R Pratt-Riccio; Vitor Ennes-Vidal; Irene S Soares; Maurício Martins Rodrigues; José Maria de Souza; Cláudio Tadeu Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz
Journal:  Malar J       Date:  2013-09-16       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.